Degradation of SARS-CoV-2 receptor ACE2 by the E3 ubiquitin ligase Skp2 in lung epithelial cells

Front Med. 2021 Apr;15(2):252-263. doi: 10.1007/s11684-021-0837-6. Epub 2021 Jan 29.

Abstract

An unexpected observation among the COVID-19 pandemic is that smokers constituted only 1.4%-18.5% of hospitalized adults, calling for an urgent investigation to determine the role of smoking in SARS-CoV-2 infection. Here, we show that cigarette smoke extract (CSE) and carcinogen benzo(a)pyrene (BaP) increase ACE2 mRNA but trigger ACE2 protein catabolism. BaP induces an aryl hydrocarbon receptor (AhR)-dependent upregulation of the ubiquitin E3 ligase Skp2 for ACE2 ubiquitination. ACE2 in lung tissues of non-smokers is higher than in smokers, consistent with the findings that tobacco carcinogens downregulate ACE2 in mice. Tobacco carcinogens inhibit SARS-CoV-2 spike protein pseudovirions infection of the cells. Given that tobacco smoke accounts for 8 million deaths including 2.1 million cancer deaths annually and Skp2 is an oncoprotein, tobacco use should not be recommended and cessation plan should be prepared for smokers in COVID-19 pandemic.

Keywords: ACE2; SARS-CoV-2; Skp2; benzo(a)pyrene; tobacco smoke.

MeSH terms

  • Adult
  • Animals
  • COVID-19*
  • Epithelial Cells
  • Humans
  • Lung
  • Mice
  • Pandemics*
  • Peptidyl-Dipeptidase A
  • SARS-CoV-2
  • Spike Glycoprotein, Coronavirus
  • Ubiquitin-Protein Ligases / genetics

Substances

  • Spike Glycoprotein, Coronavirus
  • spike protein, SARS-CoV-2
  • Ubiquitin-Protein Ligases
  • Peptidyl-Dipeptidase A